Acme United Corporation (ACU) Stock Competitors & Peer Comparison
See (ACU) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACU | $44.29 | +4.11% | 169M | 19.11 | $2.32 | +1.46% |
| PG | $145.30 | +3.64% | 327.8B | 20.58 | $6.84 | +3.03% |
| UL | $56.20 | +1.60% | 119.2B | 18.23 | $3.02 | +4.15% |
| CL | $87.94 | +3.62% | 68.1B | 32.99 | $2.58 | +2.47% |
| KVUE | $17.42 | +3.48% | 32.4B | 20.11 | $0.84 | +4.95% |
| KMB | $97.09 | +2.45% | 31.4B | 18.27 | $5.17 | +5.40% |
| EL | $83.07 | +1.24% | 30B | -118.46 | -$0.70 | +1.71% |
| CHD | $95.81 | +3.14% | 22.3B | 30.96 | $3.04 | +1.29% |
| SGI | $68.44 | +1.53% | 14.6B | 27.86 | $2.50 | +0.93% |
| CLX | $92.40 | +4.37% | 10.8B | 14.57 | $6.15 | +5.56% |
Stock Comparison
ACU vs PG Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, PG has a market cap of 327.8B. Regarding current trading prices, ACU is priced at $44.29, while PG trades at $145.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas PG's P/E ratio is 20.58. In terms of profitability, ACU's ROE is +0.08%, compared to PG's ROE of +0.31%. Regarding short-term risk, ACU is less volatile compared to PG. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check PG's competition here
ACU vs UL Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, UL has a market cap of 119.2B. Regarding current trading prices, ACU is priced at $44.29, while UL trades at $56.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas UL's P/E ratio is 18.23. In terms of profitability, ACU's ROE is +0.08%, compared to UL's ROE of +0.36%. Regarding short-term risk, ACU is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check UL's competition here
ACU vs CL Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, CL has a market cap of 68.1B. Regarding current trading prices, ACU is priced at $44.29, while CL trades at $87.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas CL's P/E ratio is 32.99. In terms of profitability, ACU's ROE is +0.08%, compared to CL's ROE of +4.75%. Regarding short-term risk, ACU is less volatile compared to CL. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check CL's competition here
ACU vs KVUE Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, KVUE has a market cap of 32.4B. Regarding current trading prices, ACU is priced at $44.29, while KVUE trades at $17.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas KVUE's P/E ratio is 20.11. In terms of profitability, ACU's ROE is +0.08%, compared to KVUE's ROE of +0.15%. Regarding short-term risk, ACU is less volatile compared to KVUE. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check KVUE's competition here
ACU vs KMB Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, KMB has a market cap of 31.4B. Regarding current trading prices, ACU is priced at $44.29, while KMB trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas KMB's P/E ratio is 18.27. In terms of profitability, ACU's ROE is +0.08%, compared to KMB's ROE of +1.44%. Regarding short-term risk, ACU is less volatile compared to KMB. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check KMB's competition here
ACU vs EL Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, EL has a market cap of 30B. Regarding current trading prices, ACU is priced at $44.29, while EL trades at $83.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas EL's P/E ratio is -118.46. In terms of profitability, ACU's ROE is +0.08%, compared to EL's ROE of -0.06%. Regarding short-term risk, ACU is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check EL's competition here
ACU vs CHD Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, CHD has a market cap of 22.3B. Regarding current trading prices, ACU is priced at $44.29, while CHD trades at $95.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas CHD's P/E ratio is 30.96. In terms of profitability, ACU's ROE is +0.08%, compared to CHD's ROE of +0.17%. Regarding short-term risk, ACU is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CHD's competition here
ACU vs SGI Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, SGI has a market cap of 14.6B. Regarding current trading prices, ACU is priced at $44.29, while SGI trades at $68.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas SGI's P/E ratio is 27.86. In terms of profitability, ACU's ROE is +0.08%, compared to SGI's ROE of +0.17%. Regarding short-term risk, ACU is less volatile compared to SGI. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check SGI's competition here
ACU vs CLX Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, CLX has a market cap of 10.8B. Regarding current trading prices, ACU is priced at $44.29, while CLX trades at $92.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas CLX's P/E ratio is 14.57. In terms of profitability, ACU's ROE is +0.08%, compared to CLX's ROE of +28.26%. Regarding short-term risk, ACU is less volatile compared to CLX. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check CLX's competition here
ACU vs NTCO Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, ACU is priced at $44.29, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas NTCO's P/E ratio is -11.37. In terms of profitability, ACU's ROE is +0.08%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, ACU is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check NTCO's competition here
ACU vs ELF Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, ELF has a market cap of 3.1B. Regarding current trading prices, ACU is priced at $44.29, while ELF trades at $49.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas ELF's P/E ratio is 116.90. In terms of profitability, ACU's ROE is +0.08%, compared to ELF's ROE of +0.05%. Regarding short-term risk, ACU is less volatile compared to ELF. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check ELF's competition here
ACU vs IPAR Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, IPAR has a market cap of 2.8B. Regarding current trading prices, ACU is priced at $44.29, while IPAR trades at $89.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas IPAR's P/E ratio is 16.87. In terms of profitability, ACU's ROE is +0.08%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, ACU is less volatile compared to IPAR. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check IPAR's competition here
ACU vs SPB Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, SPB has a market cap of 1.9B. Regarding current trading prices, ACU is priced at $44.29, while SPB trades at $82.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas SPB's P/E ratio is 15.96. In terms of profitability, ACU's ROE is +0.08%, compared to SPB's ROE of +0.07%. Regarding short-term risk, ACU is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SPB's competition here
ACU vs NWL Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, NWL has a market cap of 1.6B. Regarding current trading prices, ACU is priced at $44.29, while NWL trades at $3.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas NWL's P/E ratio is -5.73. In terms of profitability, ACU's ROE is +0.08%, compared to NWL's ROE of -0.11%. Regarding short-term risk, ACU is less volatile compared to NWL. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check NWL's competition here
ACU vs COTY Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, COTY has a market cap of 1.6B. Regarding current trading prices, ACU is priced at $44.29, while COTY trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas COTY's P/E ratio is -2.97. In terms of profitability, ACU's ROE is +0.08%, compared to COTY's ROE of -0.15%. Regarding short-term risk, ACU is less volatile compared to COTY. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check COTY's competition here
ACU vs EPC Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, EPC has a market cap of 909.2M. Regarding current trading prices, ACU is priced at $44.29, while EPC trades at $20.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas EPC's P/E ratio is -85.78. In terms of profitability, ACU's ROE is +0.08%, compared to EPC's ROE of -0.05%. Regarding short-term risk, ACU is less volatile compared to EPC. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check EPC's competition here
ACU vs HELE Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, HELE has a market cap of 582.1M. Regarding current trading prices, ACU is priced at $44.29, while HELE trades at $24.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas HELE's P/E ratio is -0.64. In terms of profitability, ACU's ROE is +0.08%, compared to HELE's ROE of -0.95%. Regarding short-term risk, ACU is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check HELE's competition here
ACU vs EWCZ Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, ACU is priced at $44.29, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, ACU's ROE is +0.08%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, ACU is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check EWCZ's competition here
ACU vs NUS Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, NUS has a market cap of 258M. Regarding current trading prices, ACU is priced at $44.29, while NUS trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas NUS's P/E ratio is 4.92. In terms of profitability, ACU's ROE is +0.08%, compared to NUS's ROE of +0.07%. Regarding short-term risk, ACU is less volatile compared to NUS. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check NUS's competition here
ACU vs PTNM Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, ACU is priced at $44.29, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas PTNM's P/E ratio is 346.33. In terms of profitability, ACU's ROE is +0.08%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, ACU is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check PTNM's competition here
ACU vs SLSN Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, SLSN has a market cap of 95M. Regarding current trading prices, ACU is priced at $44.29, while SLSN trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas SLSN's P/E ratio is 134.50. In terms of profitability, ACU's ROE is +0.08%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, ACU is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check SLSN's competition here
ACU vs SKIN Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, SKIN has a market cap of 79.1M. Regarding current trading prices, ACU is priced at $44.29, while SKIN trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas SKIN's P/E ratio is -4.69. In terms of profitability, ACU's ROE is +0.08%, compared to SKIN's ROE of -0.09%. Regarding short-term risk, ACU is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check SKIN's competition here
ACU vs GROV Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, GROV has a market cap of 52.1M. Regarding current trading prices, ACU is priced at $44.29, while GROV trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas GROV's P/E ratio is -4.59. In terms of profitability, ACU's ROE is +0.08%, compared to GROV's ROE of -1.06%. Regarding short-term risk, ACU is more volatile compared to GROV. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check GROV's competition here
ACU vs AXIL Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, AXIL has a market cap of 47.2M. Regarding current trading prices, ACU is priced at $44.29, while AXIL trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas AXIL's P/E ratio is 57.67. In terms of profitability, ACU's ROE is +0.08%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, ACU is more volatile compared to AXIL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check AXIL's competition here
ACU vs UG Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, UG has a market cap of 32.2M. Regarding current trading prices, ACU is priced at $44.29, while UG trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas UG's P/E ratio is 13.48. In terms of profitability, ACU's ROE is +0.08%, compared to UG's ROE of +0.21%. Regarding short-term risk, ACU is less volatile compared to UG. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check UG's competition here
ACU vs MTEX Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, MTEX has a market cap of 10.8M. Regarding current trading prices, ACU is priced at $44.29, while MTEX trades at $5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas MTEX's P/E ratio is -0.84. In terms of profitability, ACU's ROE is +0.08%, compared to MTEX's ROE of -23.83%. Regarding short-term risk, ACU is less volatile compared to MTEX. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check MTEX's competition here
ACU vs PHH Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, ACU is priced at $44.29, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas PHH's P/E ratio is -0.53. In terms of profitability, ACU's ROE is +0.08%, compared to PHH's ROE of +0.38%. Regarding short-term risk, ACU is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check PHH's competition here
ACU vs RAY Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, RAY has a market cap of 9.3M. Regarding current trading prices, ACU is priced at $44.29, while RAY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas RAY's P/E ratio is 4.20. In terms of profitability, ACU's ROE is +0.08%, compared to RAY's ROE of +0.09%. Regarding short-term risk, ACU is less volatile compared to RAY. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check RAY's competition here
ACU vs DSY Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, DSY has a market cap of 8.8M. Regarding current trading prices, ACU is priced at $44.29, while DSY trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas DSY's P/E ratio is -0.21. In terms of profitability, ACU's ROE is +0.08%, compared to DSY's ROE of +14.77%. Regarding short-term risk, ACU is more volatile compared to DSY. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check DSY's competition here
ACU vs BRSH Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, ACU is priced at $44.29, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas BRSH's P/E ratio is -0.01. In terms of profitability, ACU's ROE is +0.08%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, ACU is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check BRSH's competition here
ACU vs TANH Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, TANH has a market cap of 2.6M. Regarding current trading prices, ACU is priced at $44.29, while TANH trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas TANH's P/E ratio is -0.03. In terms of profitability, ACU's ROE is +0.08%, compared to TANH's ROE of -0.25%. Regarding short-term risk, ACU is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check TANH's competition here
ACU vs DSYWW Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, DSYWW has a market cap of 1.1M. Regarding current trading prices, ACU is priced at $44.29, while DSYWW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas DSYWW's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.08%, compared to DSYWW's ROE of +14.77%. Regarding short-term risk, ACU is less volatile compared to DSYWW. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check DSYWW's competition here
ACU vs TKLF Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, TKLF has a market cap of 800K. Regarding current trading prices, ACU is priced at $44.29, while TKLF trades at $1.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas TKLF's P/E ratio is 1.72. In terms of profitability, ACU's ROE is +0.08%, compared to TKLF's ROE of +0.17%. Regarding short-term risk, ACU is less volatile compared to TKLF. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check TKLF's competition here
ACU vs BRSHW Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, ACU is priced at $44.29, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas BRSHW's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.08%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, ACU is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check BRSHW's competition here
ACU vs RDEN Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, ACU is priced at $44.29, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas RDEN's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.08%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, ACU is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check RDEN's competition here
ACU vs SUMR Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, ACU is priced at $44.29, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas SUMR's P/E ratio is -3.66. In terms of profitability, ACU's ROE is +0.08%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, ACU is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SUMR's competition here
ACU vs GROV-WT Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, ACU is priced at $44.29, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.08%, compared to GROV-WT's ROE of -1.06%. Regarding short-term risk, ACU is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check GROV-WT's competition here
ACU vs REV Comparison June 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 169M. In comparison, REV has a market cap of 0. Regarding current trading prices, ACU is priced at $44.29, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 19.11, whereas REV's P/E ratio is -1.19. In terms of profitability, ACU's ROE is +0.08%, compared to REV's ROE of +0.89%. Regarding short-term risk, ACU is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check REV's competition here